Clinical Trial Update: Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing ranibizumab monotherapy with combined verteporfin therapy for subfoveal choroidal neovascularization due to age-related macul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Choroidal Neovascularization

Drugs mentioned

• Lucentis (ranibizumab)
• Visudyne (verteporfin)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Choroidal Neovascularization, Age-Related Macular Degeneration | Phase 3 | Status: COMPLETED